Phibro Animal Health Corporation (PAHC) DCF Valuation

Phibro Animal Health Corporation (PAHC) Évaluation DCF

US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ
Phibro Animal Health Corporation (PAHC) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Phibro Animal Health Corporation (PAHC) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Que vous soyez un investisseur ou un analyste, cette calculatrice DCF (PAHC) est votre ressource incontournable pour une évaluation précise. Chargé de données réelles de Phibro Animal Health Corporation, vous pouvez ajuster les prévisions et observer instantanément les effets.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 800.4 833.4 942.3 977.9 1,017.7 1,081.4 1,149.1 1,221.0 1,297.4 1,378.6
Revenue Growth, % 0 4.12 13.07 3.78 4.07 6.26 6.26 6.26 6.26 6.26
EBITDA 102.2 105.5 114.8 116.6 84.6 125.1 132.9 141.3 150.1 159.5
EBITDA, % 12.76 12.66 12.18 11.93 8.31 11.57 11.57 11.57 11.57 11.57
Depreciation 32.3 31.9 32.7 34.0 36.2 39.7 42.2 44.9 47.7 50.7
Depreciation, % 4.04 3.83 3.47 3.48 3.55 3.67 3.67 3.67 3.67 3.67
EBIT 69.8 73.6 82.1 82.6 48.4 85.4 90.7 96.4 102.4 108.8
EBIT, % 8.72 8.83 8.71 8.45 4.76 7.9 7.9 7.9 7.9 7.9
Total Cash 91.3 93.2 91.2 81.3 114.6 112.1 119.2 126.6 134.6 143.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 126.5 146.9 166.5 163.5 169.5
Account Receivables, % 15.81 17.62 17.67 16.72 16.65
Inventories 196.7 216.3 259.2 277.6 265.9 286.7 304.6 323.7 343.9 365.4
Inventories, % 24.57 25.96 27.5 28.38 26.13 26.51 26.51 26.51 26.51 26.51
Accounts Payable 62.3 68.4 95.6 73.9 85.6 91.0 96.7 102.8 109.2 116.0
Accounts Payable, % 7.78 8.2 10.14 7.55 8.41 8.42 8.42 8.42 8.42 8.42
Capital Expenditure -34.0 -29.3 -37.0 -51.8 -41.2 -45.5 -48.4 -51.4 -54.6 -58.0
Capital Expenditure, % -4.25 -3.52 -3.93 -5.3 -4.05 -4.21 -4.21 -4.21 -4.21 -4.21
Tax Rate, % 77.87 77.87 77.87 77.87 77.87 77.87 77.87 77.87 77.87 77.87
EBITAT 42.2 60.2 55.8 49.8 10.7 50.0 53.1 56.4 60.0 63.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -220.4 28.9 16.2 -5.1 23.1 15.7 23.3 24.7 26.3 27.9
WACC, % 5.06 5.38 5.17 5.05 4.47 5.03 5.03 5.03 5.03 5.03
PV UFCF
SUM PV UFCF 100.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 28
Terminal Value 940
Present Terminal Value 736
Enterprise Value 837
Net Debt 455
Equity Value 382
Diluted Shares Outstanding, MM 41
Equity Value Per Share 9.42

What You Will Get

  • Real PAHC Financials: Access to historical and projected data for precise valuation.
  • Adjustable Inputs: Customize WACC, tax rates, revenue growth, and capital expenditures.
  • Automatic Calculations: Dynamic computation of intrinsic value and NPV.
  • Scenario Analysis: Evaluate various scenarios to assess Phibro’s future performance.
  • Clear and Intuitive Design: Designed for professionals but easy to use for beginners.

Key Features

  • Accurate Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Phibro Animal Health Corporation (PAHC).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries to effectively visualize your valuation outcomes.
  • Designed for All Skill Levels: A straightforward, user-friendly layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Step 1: Download the Excel file for Phibro Animal Health Corporation (PAHC).
  2. Step 2: Review the pre-filled financial data and forecasts specific to Phibro Animal Health.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
  5. Step 5: Evaluate the results and utilize the findings for your investment strategies.

Why Choose This Calculator for Phibro Animal Health Corporation (PAHC)?

  • Designed for Industry Experts: A sophisticated tool tailored for veterinarians, animal nutritionists, and financial analysts.
  • Comprehensive Data: PAHC’s historical and projected financials included for precise calculations.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Intuitive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly Interface: Step-by-step guidance makes the process straightforward.

Who Should Use This Product?

  • Investors: Accurately assess Phibro Animal Health Corporation’s (PAHC) fair value prior to making investment choices.
  • CFOs: Utilize a high-quality DCF model for financial reporting and analysis related to Phibro Animal Health Corporation.
  • Consultants: Efficiently customize the template for valuation reports tailored to clients involving Phibro Animal Health Corporation.
  • Entrepreneurs: Acquire knowledge about financial modeling practices employed by leading companies in the animal health sector.
  • Educators: Implement it as a teaching resource to illustrate various valuation methodologies relevant to Phibro Animal Health Corporation.

What the Template Contains

  • Pre-Filled DCF Model: Phibro Animal Health Corporation’s (PAHC) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Phibro’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.